Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

Oral Cancer

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Oral Cancer

51 trials tracked for Oral Cancer: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 150 citations.

51Trials tracked

6Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 3 6 Phase 2 36 Phase 1 2 Other / NA 7

Phase 3 Erlotinib Prevention of Oral Cancer (EPOC) Completed · 150 cited
Phase 3 Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Completed · 53 cited
Phase 3 Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Completed · 4 cited
Phase 3 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Completed
Phase 3 DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer Completed
Phase 3 GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed

Show 44 more trials

Phase 2 GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer Completed
Phase 2 Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Completed
Phase 2 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed
Phase 2 Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions Completed
Phase 2 Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma Completed
Phase 2 Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck Completed
Phase 2 F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients Completed
Phase 2 Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer Completed
Phase 2 Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer Completed
Phase 2 Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer Completed
Phase 2 Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia Completed
Phase 2 Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Completed
Phase 2 IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity Completed
Phase 2 Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia Completed
Phase 2 Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin Completed
Phase 2 Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Completed
Phase 2 Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention Completed
Phase 2 Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma Completed
Phase 2 Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma Completed
Phase 2 Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Completed
Phase 2 Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab Completed
Phase 2 Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma Completed
Phase 2 Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Completed
Phase 2 Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Completed
Phase 2 Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery Completed
Phase 2 Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer Completed
Phase 2 Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck Completed
Phase 2 Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Completed
Phase 2 Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity Completed
Phase 2 PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Completed
Phase 2 SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Completed
Phase 2 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Completed
Phase 2 Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy Completed
Phase 2 Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer Completed
Phase 2 Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer. Completed
Phase 2 Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Completed
Phase 1 Inhibition of Oral Tumorigenesis by Antitumor B Completed
Phase 1 Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Completed
N/A Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis Completed
N/A Oral Pathology Asynchronous Telementoring Pilot Study Completed
N/A Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase Completed
N/A Evaluations of Alcohol Warning Labels Completed
N/A Prevention of Oral DNA Damage by Black Raspberries Completed
N/A Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer Completed

Showing the 50 most-cited and recently-updated of 51 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.